News

Hydroxychloroquine added and Trimethoprim Sulfamethoxazole moved on lists

Update for Online Version of My Medicines Forms

Hydroxyzine and metoclopramide were added to the list of drugs that cause Torsades de Pointes (TdP) under certain clinical conditions.

TUCSON, AZ – CredibleMeds®, the internationally recognized authority on drug safety, has been awarded a three-year contract from the Safe Use Initiative of the U.S. Food and Drug Administration (FDA) to further their mutual goal of promoting and facilitating the safe use of medicines. Several thousand people in the US die each year from taking certain commonly prescribed antibiotics that have heart toxicity, when safer alternatives could be identified. 

Extended use of Pantoprazole (Protonix®) and risk of low serum magnesium and cardiac arrhythmias.

Recent publications in the medical literature have cited increased mortality associated with erythromycin, azithromycin, and levofloxacin. In a search for a possible explanation for the increased number of deaths with these drugs

In the last 9 months, over 153,000 unique visitors from 174 countries have accessed the CredibleMeds® website. This represents a 29 increase and 48% of visitors are from outside the U.S.

Using the list of QT prolonging drugs from the CredibleMeds website and patient information in the electronic health records, the CDSS automatically generated a risk score for QT prolongation and issued alerts to pharmacists (high risk or moderate risk).

Nelfinavir (Viracept®) and Ivabradine (Procoralan®, Coralan®, Corlentor®, Coraxan®, Ivabid®, Bradia®) have been added to the list of medicines with Conditional Risk of Torsades de Pointes (TdP).

Azithromycin has been associated with increased risk of death(1) and since June 2012 has been on the CredibleMeds list of QT-prolonging drugs that have “Known Risk of Torsades de Pointes (TdP).”